QA102 Phase II Study in Subjects With Dry AMD

PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

September 22, 2022

Primary Completion Date

November 12, 2024

Study Completion Date

November 12, 2024

Conditions

Dry Age-related Macular Degeneration

Interventions

DRUG

QA102/Placebo

Capsules

DRUG

QA102

Capsules

DRUG

Placebo

Capsules

Trial Locations (1)

Texas Retina Associates - Plano, Plano

All Listed Sponsors

lead

Smilebiotek Zhuhai Limited

INDUSTRY